Trial Information
Breast Cancer Care (BRECC) Registry - Development of a Breast Cancer Registry to Determine the Magnitude of Breast Cancer and Current Clinical Care Patterns in Kenya
Inclusion Criteria:
- Histologically or cytologically confirmed breast cancer
- No previous interventional therapy for breast cancer
- Ability to provide written informed consent as per GCP and local regulations
Exclusion Criteria:
- Participation in other clinical study where the diagnosis and treatment protocol is
stated prior to enrolment
- Inability to assess and follow up patient outcomes, for example quality of life due
to psychiatric illness or WHO/ECOG performance status IV or worse
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Incidence of breast cancer in Kenya
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
Kenya: National Council for Science and Technology
Study ID:
ML25502
NCT ID:
NCT01484483
Start Date:
August 2011
Completion Date:
December 2017
Related Keywords:
- Breast Cancer
- Breast Neoplasms